Page last updated: 2024-09-04

levofloxacin and 4-hydroxy-2-nonenal

levofloxacin has been researched along with 4-hydroxy-2-nonenal in 1 studies

Compound Research Comparison

Studies (levofloxacin)	Trials (levofloxacin)	Recent Studies (post-2010) (levofloxacin)	Studies (4-hydroxy-2-nonenal)	Trials (4-hydroxy-2-nonenal)	Recent Studies (post-2010) (4-hydroxy-2-nonenal)
4,346	581	2,209	3,034	26	1,103

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ge, T; Jiang, J; Sheng, S; Song, M; Wang, G; Wu, H; Wu, S; Zhou, Y	1

Other Studies

1 other study(ies) available for levofloxacin and 4-hydroxy-2-nonenal

Article	Year
Antibiotic drug levofloxacin inhibits proliferation and induces apoptosis of lung cancer cells through inducing mitochondrial dysfunction and oxidative damage. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 84 Topics: Aldehydes; Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA Damage; Dose-Response Relationship, Drug; Electron Transport Complex I; Electron Transport Complex III; Humans; Levofloxacin; Lung Neoplasms; Mice, SCID; Mitochondria; Oxidative Stress; Reactive Oxygen Species; Tumor Burden; Xenograft Model Antitumor Assays	2016

Article

Year

Antibiotic drug levofloxacin inhibits proliferation and induces apoptosis of lung cancer cells through inducing mitochondrial dysfunction and oxidative damage.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 84

Topics: Aldehydes; Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA Damage; Dose-Response Relationship, Drug; Electron Transport Complex I; Electron Transport Complex III; Humans; Levofloxacin; Lung Neoplasms; Mice, SCID; Mitochondria; Oxidative Stress; Reactive Oxygen Species; Tumor Burden; Xenograft Model Antitumor Assays

2016